Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Merck KGaA Partners with IMEC to Develop Advanced Microphysiological Systems Platform
CompanyDeals

Merck KGaA Partners with IMEC to Develop Advanced Microphysiological Systems Platform

May 21, 2025
Antengene and MSD Collaborate on ATG-022 for Advanced Solid Tumors
CompanyDeals

Antengene and MSD Collaborate on ATG-022 for Advanced Solid Tumors

May 21, 2025
China's County Hospitals Show Improved Medical Service Capability in 2024
HospitalPolicy / Regulatory

China’s County Hospitals Show Improved Medical Service Capability in 2024

May 21, 2025
3SBio Registers Phase III Study for SSGJ-707 in Advanced NSCLC
CompanyDrug

3SBio Registers Phase III Study for SSGJ-707 in Advanced NSCLC

May 21, 2025
Ascletis Pharma Initiates ASC47-103 Study in US for Obesity Treatment
CompanyDrug

Ascletis Pharma Initiates ASC47-103 Study in US for Obesity Treatment

May 21, 2025
Yifan Pharma Licenses Ryzneuta to Lenis for Balkan Markets
CompanyDeals

Yifan Pharma Licenses Ryzneuta to Lenis for Balkan Markets

May 21, 2025
Abbisko's Pimitinib Granted Priority Review for TGCT Treatment in China
CompanyDrug

Abbisko’s Pimitinib Granted Priority Review for TGCT Treatment in China

May 21, 2025
Minghui Pharmaceutical Launches Phase II Study of Combination Therapy for Advanced NSCLC
CompanyDrug

Minghui Pharmaceutical Launches Phase II Study of Combination Therapy for Advanced NSCLC

May 21, 2025
CSPC Pharmaceutical Gains NMPA Approval for JMT106 Clinical Study in Solid Tumors
CompanyDrug

CSPC Pharmaceutical Gains NMPA Approval for JMT106 Clinical Study in Solid Tumors

May 21, 2025
Zhaoke Ophthalmology's Cyclosporine Eye Gel NDA Accepted by NMPA
CompanyDrug

Zhaoke Ophthalmology’s Cyclosporine Eye Gel NDA Accepted by NMPA

May 21, 2025
Johnson & Johnson MedTech Completes First PFA Surgeries with VARIPULSE Catheter in China
CompanyMedical Device

Johnson & Johnson MedTech Completes First PFA Surgeries with VARIPULSE Catheter in China

May 21, 2025
Shanghai CureGene Completes Series B+ Financing to Advance CG-0255 Study
CompanyDeals

Shanghai CureGene Completes Series B+ Financing to Advance CG-0255 Study

May 21, 2025
1 2 … 159 160 161 162 163 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up